Inotersen

Thrombocytopenia and Glomerulonephritis

Thrombocytopenia

• TEGSEDI causes reductions in platelet count that may result in sudden and unpredictable thrombocytopenia, which can be lifethreatening. Testing prior to treatment and monitoring during treatment is required.

Glomerulonephritis

• TEGSEDI can cause glomerulonephritis that may require immunosuppressive treatment and may result in dialysisdependent renal failure. Testing prior to treatment and monitoring during treatment is required. 

Approved Risk Evaluation and Mitigation Strategies (REMS)

TEGSEDI (Inotersen) Injection

Patient Counseling Information

• TEGSEDI

Medication Guides

Patient Medication Guide - TEGSEDI

Package Inserts

Inotersen